Universal Biosensors Statistics

Total Valuation

ASX:UBIO has a market cap or net worth of AUD 10.73 million. The enterprise value is 9.72 million.

Market Cap	10.73M
Enterprise Value	9.72M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+37.00%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	192.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.69
PB Ratio	0.79
P/TBV Ratio	0.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.66
EV / Sales	1.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.91

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.26.

Current Ratio	2.99
Quick Ratio	1.08
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	-1,105.05

Financial Efficiency

Return on equity (ROE) is -90.95% and return on invested capital (ROIC) is -55.19%.

Return on Equity (ROE)	-90.95%
Return on Assets (ROA)	-44.24%
Return on Invested Capital (ROIC)	-55.19%
Return on Capital Employed (ROCE)	-102.98%
Revenue Per Employee	83,788
Profits Per Employee	-192,617
Employee Count	76
Asset Turnover	0.25
Inventory Turnover	0.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.68
Average Volume (20 Days)	119,823

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:UBIO had revenue of AUD 6.37 million and -14.64 million in losses. Loss per share was -0.05.

Revenue	6.37M
Gross Profit	3.97M
Operating Income	-17.78M
Pretax Income	-14.64M
Net Income	-14.64M
EBITDA	-17.07M
EBIT	-17.78M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 4.56 million in cash and 3.55 million in debt, giving a net cash position of 1.01 million.

Cash & Cash Equivalents	4.56M
Total Debt	3.55M
Net Cash	1.01M
Net Cash Per Share	n/a
Equity (Book Value)	13.53M
Book Value Per Share	0.05
Working Capital	10.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.28 million and capital expenditures -365,621, giving a free cash flow of -10.64 million.

Operating Cash Flow	-10.28M
Capital Expenditures	-365,621
Free Cash Flow	-10.64M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.31%, with operating and profit margins of -279.24% and -229.89%.

Gross Margin	62.31%
Operating Margin	-279.24%
Pretax Margin	-229.89%
Profit Margin	-229.89%
EBITDA Margin	-268.03%
EBIT Margin	-279.24%
FCF Margin	n/a

Dividends & Yields

ASX:UBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.00%
Shareholder Yield	n/a
Earnings Yield	-136.42%
FCF Yield	-99.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:UBIO has an Altman Z-Score of -6.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.66
Piotroski F-Score	n/a